Agilon Health (NYSE:AGL) Rating Increased to Equal Weight at Barclays

Agilon Health (NYSE:AGL) was upgraded by equities researchers at Barclays from an “underweight” rating to an “equal weight” rating in a research note issued to investors on Tuesday. The firm currently has a $81.00 price objective on the stock. Barclays‘s price target would indicate a potential downside of 5.68% from the stock’s previous close.

A number of other equities analysts have also weighed in on the company. Robert W. Baird boosted their price objective on Agilon Health from $20.00 to $35.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. JPMorgan Chase & Co. lowered Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price objective on the stock. in a research note on Monday, May 4th. Benchmark reissued a “buy” rating and set a $95.00 price objective (up from $13.00) on shares of Agilon Health in a research note on Thursday. Wall Street Zen raised Agilon Health from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Finally, TD Cowen reissued a “hold” rating and set a $55.00 price objective (up from $17.00) on shares of Agilon Health in a research note on Monday, May 11th. Five research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Agilon Health has an average rating of “Hold” and an average price target of $58.73.

Agilon Health Stock Performance

Shares of NYSE:AGL opened at $85.88 on Tuesday. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04. The business’s 50 day moving average price is $33.62 and its 200-day moving average price is $22.87. The firm has a market capitalization of $1.43 billion, a PE ratio of -3.98 and a beta of 2.29. Agilon Health has a 1 year low of $7.48 and a 1 year high of $90.48.

Agilon Health (NYSE:AGL) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%. As a group, equities research analysts expect that Agilon Health will post -3.75 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. CenterBook Partners LP raised its position in Agilon Health by 492.4% in the third quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock valued at $11,771,000 after purchasing an additional 9,499,012 shares during the period. Independent Advisor Alliance purchased a new stake in shares of Agilon Health in the 3rd quarter valued at $39,000. Y Intercept Hong Kong Ltd purchased a new stake in Agilon Health during the 3rd quarter worth about $90,000. Pilgrim Partners Asia Pte Ltd purchased a new stake in Agilon Health during the 3rd quarter worth about $37,000. Finally, Simplify Asset Management Inc. increased its holdings in Agilon Health by 92.0% during the 4th quarter. Simplify Asset Management Inc. now owns 218,810 shares of the company’s stock worth $151,000 after purchasing an additional 104,834 shares during the period.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.